Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Herbert Kim Lyerly

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Expert Opinion on Biological Therapy|February 9, 2020
DC-CIK as a widely applicable cancer immunotherapyShuo Wang, Xiaoli Wang, Xinna Zhou, et al.
IEEE Transactions on Bio-Medical Engineering|November 26, 2019
Miniaturized Intracavitary Forward-Looking Ultrasound Transducer for Tissue AblationHowuk Kim, Huaiyu Wu, Namwoo Cho, et al.
Cytotherapy|October 10, 2017
Circulating CD8<sup>+</sup>CD28<sup>-</sup> suppressor T cells tied to poorer prognosis among metastatic breast cancer patients receiving adoptive T-cell therapy: A cohort studyQingkun Song, Jun Ren, Xinna Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2020
Novel Therapeutic Interventions Early in the Disease Trajectory: Drug Development Beyond the Refractory SettingNavid Hafez, Hope S Rugo, Margaret A Tempero, et al.
Journal of Pain and Symptom Management|April 28, 2009
Feasibility and acceptability to patients of a longitudinal system for evaluating cancer-related symptoms and quality of life: pilot study of an e/Tablet data-collection system in academic oncologyAmy P Abernethy, James E Herndon, Jane L Wheeler, et al.
Breast Cancer Research : BCR|April 8, 2015
Perhexiline promotes HER3 ablation through receptor internalization and inhibits tumor growthXiu-Rong Ren, Jiangbo Wang, Takuya Osada, et al.
Cancer Immunology, Immunotherapy : CII|April 23, 2013
Elevated level of peripheral CD8(+)CD28(-) T lymphocytes are an independent predictor of progression-free survival in patients with metastatic breast cancer during the course of chemotherapyGuohong Song, Xiaoli Wang, Jun Jia, et al.
Pain|October 1, 2019
Adoptive immunotherapy with autologous T-cell infusions reduces opioid requirements in advanced cancer patientsXinna Zhou, Guoliang Qiao, Jun Ren, et al.
American Journal of Cancer Research|January 8, 2021
Infiltration of metastatic lymph nodes with PD-1<sup>+</sup> T cells is associated with improved disease-free and overall survival in resected N<sup>+</sup> NSCLCShuo Wang, Yuguang Song, Michael A Morse, et al.
Theranostics|June 20, 2020
An age-independent gene signature for monitoring acute rejection in kidney transplantationBrian I Shaw, Daniel K Cheng, Chaitanya R Acharya, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Expert Opinion on Biological Therapy|February 9, 2020
DC-CIK as a widely applicable cancer immunotherapyShuo Wang, Xiaoli Wang, Xinna Zhou, et al.
IEEE Transactions on Bio-Medical Engineering|November 26, 2019
Miniaturized Intracavitary Forward-Looking Ultrasound Transducer for Tissue AblationHowuk Kim, Huaiyu Wu, Namwoo Cho, et al.
Cytotherapy|October 10, 2017
Circulating CD8<sup>+</sup>CD28<sup>-</sup> suppressor T cells tied to poorer prognosis among metastatic breast cancer patients receiving adoptive T-cell therapy: A cohort studyQingkun Song, Jun Ren, Xinna Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2020
Novel Therapeutic Interventions Early in the Disease Trajectory: Drug Development Beyond the Refractory SettingNavid Hafez, Hope S Rugo, Margaret A Tempero, et al.
Journal of Pain and Symptom Management|April 28, 2009
Feasibility and acceptability to patients of a longitudinal system for evaluating cancer-related symptoms and quality of life: pilot study of an e/Tablet data-collection system in academic oncologyAmy P Abernethy, James E Herndon, Jane L Wheeler, et al.
Breast Cancer Research : BCR|April 8, 2015
Perhexiline promotes HER3 ablation through receptor internalization and inhibits tumor growthXiu-Rong Ren, Jiangbo Wang, Takuya Osada, et al.
Cancer Immunology, Immunotherapy : CII|April 23, 2013
Elevated level of peripheral CD8(+)CD28(-) T lymphocytes are an independent predictor of progression-free survival in patients with metastatic breast cancer during the course of chemotherapyGuohong Song, Xiaoli Wang, Jun Jia, et al.
Pain|October 1, 2019
Adoptive immunotherapy with autologous T-cell infusions reduces opioid requirements in advanced cancer patientsXinna Zhou, Guoliang Qiao, Jun Ren, et al.
American Journal of Cancer Research|January 8, 2021
Infiltration of metastatic lymph nodes with PD-1<sup>+</sup> T cells is associated with improved disease-free and overall survival in resected N<sup>+</sup> NSCLCShuo Wang, Yuguang Song, Michael A Morse, et al.
Theranostics|June 20, 2020
An age-independent gene signature for monitoring acute rejection in kidney transplantationBrian I Shaw, Daniel K Cheng, Chaitanya R Acharya, et al.
Pageof 5